Pfizer plans to close an R&D facility in the UK
Article from www.pharmalot.com (1st Februar 2011). As part of its ongoing effort to brace for the loss of the Lipitor patent, Pfizer now plans to close an R&D facility in Sandwick, Kent in the UK, which employs 2,400 jobs and was where Viagra was born.
The drugmaker will also shift some operations from its Groton, Connecticut R&D facility in the US to its Cambridge, Massachusetts site, which is being expanded, as it moves to slash $1.5 billion from R&D spending.
Read more on: